Call for Abstract

12th World Congress on Innovations in Novel Drug Delivery Systems, will be organized around the theme “Latest Trends in Pharmacy : Spanning the Gap in Research and Product Commercialization”

NDDS 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in NDDS 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

The pharmaceutical industry is responsible for the development, production and marketing of medications. Thus, its immense importance as a global sector is evident. Pharmaceutical Industry includes venture that produce synthetic and plant derived preparations, vitamins, antibiotics, blood constituents, drugs in various dosage forms .They are subjected to a variety of laws and regulations that govern the patenting, testing, safety, competence and marketing of drugs. Pharmaceutical Sciences deals with accelerated research to discover new drugs. The industry and volume of productivity is determined by its capital etc. Evolution and elevation in pharmaceutical industry helps in controlling and treating the diseases.

 

Insights and actualities about the pharmaceutical business around the world 
 
The pharmaceutical business is in charge of the improvement, creation and showcasing of prescriptions. In this way, its massive significance as a worldwide segment is apparent. The aggregate level of pharmaceutical income worldwide had achieved about one trillion U.S. dollars. North America is in charge of the biggest part, producing more than 40 percent of these incomes. This is for the most part because of the main part of the U.S. pharmaceutical industry. Be that as it may, as in numerous different ventures, the Chinese pharmaceutical segment demonstrates the most elevated development rates in the course of the most recent years.

 

  • Track 1-1 The Changing Healthcare Scene & Impact on the Pharmaceutical Industry
  • Track 1-2The Europe Pharmaceutical Industry Is Rising to Its Challenges
  • Track 1-3Universal Pharmaceutical Trade
  • Track 1-4Pharmaceutical Analytical and QA Consulting services
  • Track 1-5Key issues facing the Pharmaceutical Industry
  • Track 1-6Pharma Tech Transfer

Drug discovery is a process, which aims at identifying a compound therapeutically useful in treating and curing a disease. Typically a drug discovery effort addresses a biological target that has been shown to play a role in the development of the disease or starts from a molecule with interesting biological activities.

The process of drug discovery involves the identification of candidates, synthesis, characterization, screening, and assays for therapeutic efficacy. Once a compound has shown its value in these tests, it will begin the process of drug development prior to clinical trials. Drug discovery and development is an expensive process due to the high costs of R&D and human clinical tests. The average total cost per drug development varies from US$ 897 million to US$ 1.9 billion. The typical development time is 10-15 years. In the past most drugs have been discovered either by identifying the active ingredient from traditional remedies or by serendipitous discovery. At present a new approach is being tried to understand how disease and infection are controlled at the molecular and physiological level and to target specific entities based on this knowledge.

The worldwide market for medication revelation advancements and items came to $38.4 billion in 2011. It has extended to $41.4 billion in 2012 and to $79.0 billion by 2017, a compound yearly development rate (CAGR) of 13.8% somewhere around 2012 and 2017.

  • Track 2-1Steps in Modern Drug Discovery
  • Track 2-2Lead Discovery Methods
  • Track 2-3Advanced Technologies involved in Drug Discovery

Each year many new prescription drugs are approved by the Food and Drug Administration (FDA). The process of developing and bringing new drugs to market is important for primary care physicians to understand. A drug must undergo rigorous testing prior to marketing to and medical use by the general public. The process starts with preclinical testing. For drugs that appear safe, an investigational new drug application is filed with the FDA. If approved, clinical trials begin with phase 1 studies that focus on safety and pharmacology. Phase 2 studies examine the effectiveness of the compound. Phase 3 is the final step before submitting a new drug application (NDA) to the FDA. An NDA contains all the information obtained during all phases of testing. Phase 4 studies, or postmarketing studies, are conducted after a product is approved. Recent changes in legislation have streamlined the approval process. Critics contend that these changes have compromised public safety, resulting in the need to recall several products from the market. Proponents claim that changes in the approval process help patients with debilitating diseases, such as acquired immunodeficiency syndrome, that were previously denied critical medication because of bureaucratic regulations.

The worldwide market for medication disclosure in pharmaceuticals came to about $25.0 billion in 2013. This market is relied upon to reach $29.6 billion in 2014 and $79.8 billion in 2019, with a compound yearly development rate (CAGR) of 22.0% for the time of 2014 to 2019.

  • Track 3-1Discovery and Development
  • Track 3-2Preclinical Research
  • Track 3-3Clinical Research
  • Track 3-4FDA Review
  • Track 3-5FDA Post-Market Safety Monitoring
  • Track 3-6Drug Development Research
  • Track 3-7Drug Development Companies
  • Track 3-8Drug Characterisation

Drug Manufacturing is the process of industrial-scale synthesis of pharmaceutical drugs by pharmaceutical companies. The process of drug manufacturing can be broken down into a series of unit operations such as Milling, Granulation, Coating, Tablet pressing and others. Statistics are critical to the pharmaceutical industry, from clinical operations through manufacturing. However, clinical and manufacturing statistics represent entirely different worlds. Where they might be well staffed on the clinical side, some pharmaceutical companies today aren’t hiring qualified staff to analyze operations data, resulting in misapplied tools, inadequate CAPAs and superficial root cause analysis, all of which lead to financial loss and noncompliance.

The pharmaceutical manufacturing landscape has changed notably over the past decade and is continuing to evolve rapidly. Pharmaceutical manufacturers have begun to wield some new tools, nailing down new efficiencies and better drugs in the process.

The worldwide market for computerized material taking care of was esteemed at about $4.5 billion in 2013 and $4.8 billion in 2014. The aggregate market is anticipated to develop at a compound yearly development rate (CAGR) of 8.1% from 2014 through 2019 and reach $7.1 billion by 2019.

  • Track 4-1Automation in Pharmaceutical Manufacturing
  • Track 4-2Overview of Pharmaceutical Manufacturing Process
  • Track 4-3Pharma Contract Manufacturing

It is carried out for the purpose of safety of the Drug products in order to keep them free from contamination, hinder microbial growth, and ensure product safety through the intended shelf life for the pharmaceuticals.  Some common pharmaceutical packaging techniques include foil and heat sealing; polyester and olefin package printing; polyethylene and polypropylene printing; and flatbed die cutting.

The worldwide market for tissue building and recovery is relied upon to reach $60.8 billion by 2021 from $13.6 billion in 2016, ascending at a compound yearly development rate (CAGR) of 34.9% from 2016 through 2021.

  • Track 5-1Package Design Research and New Trends In The Pharmaceutical Packaging
  • Track 5-2Package Testing
  • Track 5-3Packaging Material
  • Track 5-4Packaging Machine
  • Track 5-5Blister And Strip Packaging
  • Track 5-6Defects In Packages
  • Track 5-7Labeling of Packages

Pharmaceutical quality affects every American. FDA regulates the quality of pharmaceuticals very carefully. The main regulatory standard for ensuring pharmaceutical quality is the Current Good Manufacturing Practice (CGMPs) regulation for human pharmaceuticals. Consumers expect that each batch of medicines they take will meet quality standards so that they will be safe and effective. Most people, however, are not aware of CGMPs, or how FDA assures that drug manufacturing processes meet these basic objectives. Recently, FDA has announced a number of regulatory actions taken against drug manufacturers based on the lack of CGMPs. This paper discusses some facts that may be helpful in understanding how CGMPs establish the foundation for drug product quality.

The worldwide market for biosimilars came to $1.7 billion in 2010 and $2.5 billion in 2011. The market is relied upon to reach $3.6 billion by 2016, a compound yearly development rate (CAGR) of 7.7%.

  • Track 6-1Facts About Current Good Manufacturing Practices (cGMPs)
  • Track 6-2Good Automated Manufacturing Practice (GAMP)
  • Track 6-3FDA Good Manufacturing Practices
  • Track 6-4GMP/GCP Interface & GMP audits
  • Track 6-5GMP Requirements & Standards

Quality is always an imperative prerequisite when we consider any product. Therefore, drugs must be manufactured to the highest quality levels. End-product testing by itself does not guarantee the quality of the product. Quality assurance techniques must be used to build the quality into the product at every step and not just tested for at the end. In pharmaceutical industry, Process Validation performs this task to build the quality into the product because according to ISO 9000:2000, it had proven to be an important tool for quality management of pharmaceuticals.

Quality cannot be adequately assured by in-process and finished inspections and testing but it should be built in to the manufacturing process. These processes should be controlled in order that the finished product meets all quality specifications. Validation is one of the important steps in achieving and maintaining the quality of the final product. If each step of production process is validated we can assure that the final product is of the best quality. Validation of the individual steps of the processes is called the process validation. Different dosage forms have different validation protocols. Process Validation is one of the important steps in achieving and maintaining the quality of final product. It gives a higher degree of assurance.

The worldwide pharma process validation advertise has developed to $39.4 billion in 2014 from $29.3 billion in 2013. The market is required to develop at a five-year compound yearly development rate (CAGR) of 13.8% from 2015 to 2020, expanding from $50.6 billion in 2015 to $96.6 billion in 2020.

  • Track 7-1Strategies for Supply Chain Optimization
  • Track 7-2Operational issues in the Pharmaceutical Supply Chain
  • Track 7-3Strategic and Design Issues in the Pharmaceutical Supply Chain
  • Track 7-4Supply Chain Design Summary
  • Track 7-5Global Supply Chain Planning

Quality is always an imperative prerequisite when we consider any product. Therefore, drugs must be manufactured to the highest quality levels. End-product testing by itself does not guarantee the quality of the product. Quality assurance techniques must be used to build the quality into the product at every step and not just tested for at the end. In pharmaceutical industry, Process Validation performs this task to build the quality into the product because according to ISO 9000:2000, it had proven to be an important tool for quality management of pharmaceuticals.

Quality cannot be adequately assured by in-process and finished inspections and testing but it should be built in to the manufacturing process. These processes should be controlled in order that the finished product meets all quality specifications. Validation is one of the important steps in achieving and maintaining the quality of the final product. If each step of production process is validated we can assure that the final product is of the best quality. Validation of the individual steps of the processes is called the process validation. Different dosage forms have different validation protocols. Process Validation is one of the important steps in achieving and maintaining the quality of final product. It gives a higher degree of assurance.

The worldwide pharma process validation advertise has developed to $39.4 billion in 2014 from $29.3 billion in 2013. The market is required to develop at a five-year compound yearly development rate (CAGR) of 13.8% from 2015 to 2020, expanding from $50.6 billion in 2015 to $96.6 billion in 2020.

  • Track 8-1 Approach to Process Validation
  • Track 8-2Validation Protocol and Report
  • Track 8-3Process Validation and Drug Quality
  • Track 8-4Types of Process Validation
  • Track 8-5Statutory and Regulatory Requirements for Process Validation

The area unit variety of motives for extending the merchandise development outside of the mature, developed economies (e.g. the EU and therefore the US) and most of them have faith in the high population and market potential of rising markets. Some reasons for this growing trend area unit result of the inevitable “patent cliff” that forces firms to any extend their reach and develop any. It's clear that rising markets supply nice market and population potential however at constant time cause sure challenges, as well as moral, GCP. Licensing in pharmaceutical production is mandatory step for pharmaceutical products. Regulatory matters is definitely acknowledged by the complete pharmaceutical community and authorities try to develop a cooperative model for harmonizing the Regulatory necessities across the regions so as to ease the world pharmaceutical development.

 

  • Track 9-1Information on Compounding
  • Track 9-2Drug Compliance Programs
  • Track 9-3FDA guidance for clinical investigations
  • Track 9-4Nicotine-Containing Products
  • Track 9-5Newly Added Guidance Documents
  • Track 9-6PLR Requirements for Prescribing Information
  • Track 9-7Regulatory Guidance Drug Registration and Listing

Medico-Marketing involves promotion of pharmaceutical products. It facilitates to continuously update physicians, nurses and pharmacists regarding the safe and effective use of medicines. Medico marketing encompasses activities by medicos or organizations to actualize markets for pharmaceutical care.

The World Health Organization defines pharmaceutical promotion as “all information and persuasive activities executed by pharmaceutical manufacturers and distributors, attempting to affect the prescription, supply, purchase, and/or use of medical drugs”.

The worldwide liver infections therapeutics showcase totaled about $24.5 billion in 2014 and is anticipated to approach $33.8 billion by 2019, enlisting a compound yearly development rate (CAGR) of 6.7% through 2019.

 

  • Track 10-1Pharma Market Structure
  • Track 10-2Pharmaceutical Sales
  • Track 10-3Pharmaceutical Sales
  • Track 10-4Rise in Pricing Pressures
  • Track 10-5Increased Importance of Emerging Markets
  • Track 10-6The Urge to Merge